Quanterix's Series D - II Round

Quanterix raised a round of funding on June 14, 2017. Investors include T. Rowe Price.

Quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. The Single Molecule Arra…

Articles about Quanterix's Series D - II Round: